VIRIDIAN THERAPEUTICS
Viridian Therapeutics provides treatments for patients with diseases that are underserved by therapies. They develops product candidates to treat patients who suffer from thyroid eye disease, a debilitating orphan disease, and early-stage programs focused on targets and indications.
VIRIDIAN THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Therapeutics
Founded:
2007-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.viridiantherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+1 617 272 4600
Total Funding:
681.7 M USD
Technology used in webpage:
Google Maps Amazon Mobile Non Scaleable Content HSTS IPv6 ReCAPTCHA Google Maps API Apple Mobile Web App Capable Amazon Virginia Region Ruby On Rails Token
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Inception Sciences
Inception Sciences creates therapies with transformative potential to address diseases and disorders with significant unmet need.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Board_member
2007-01-01
Board_member
2007-01-01
Board_observer
2007-01-01
Advisor
2007-01-01
Current Employees Featured
Paul Rubin Executive Vice-President of Research and Development @ Viridian Therapeutics
Executive Vice-President of Research and Development
2016-10-01
Kristian F. Humer CFO & Chief Business Officer @ Viridian Therapeutics
CFO & Chief Business Officer
2021-07-01
Carrie Melvin Chief Operating Officer @ Viridian Therapeutics
Chief Operating Officer
2022-01-01
Steve Mahoney President, Chief Executive Officer & Member of the Board of Directors @ Viridian Therapeutics
President, Chief Executive Officer & Member of the Board of Directors
2023-11-01
Barrett Katz Chief Medical Officer @ Viridian Therapeutics
Chief Medical Officer
2021-01-01
Jennifer Tousignant Chief Legal Officer @ Viridian Therapeutics
Chief Legal Officer
2024-02-01
Scott Myers Chief Executive Officer and President @ Viridian Therapeutics
Chief Executive Officer and President
2023-02-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-10-28 | Viridian Therapeutics | Viridian Therapeutics acquired by Viridian Therapeutics | N/A |
| 2016-11-02 | Signal Genetics | Signal Genetics acquired by Viridian Therapeutics | 60 M USD |
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Viridian Therapeutics
Remeditex Ventures
Remeditex Ventures investment in Series C - Viridian Therapeutics
Fidelity
Fidelity investment in Series C - Viridian Therapeutics
Atlas Venture
Atlas Venture investment in Series C - Viridian Therapeutics
MP Healthcare Venture Management
MP Healthcare Venture Management investment in Series C - Viridian Therapeutics
Brace Pharma
Brace Pharma investment in Series C - Viridian Therapeutics
JAFCO
JAFCO investment in Series C - Viridian Therapeutics
Boulder Ventures
Boulder Ventures investment in Series C - Viridian Therapeutics
MRL Ventures Fund
MRL Ventures Fund investment in Series C - Viridian Therapeutics
Remeditex Ventures
Remeditex Ventures investment in Series B - Viridian Therapeutics
Key Employee Changes
Official Site Inspections
http://www.viridiantherapeutics.com Semrush global rank: 3.07 M Semrush visits lastest month: 5.05 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Viridian Therapeutics"
Our Company - Viridian Therapeutics, Inc.
Sep 11, 2023 At Viridian Therapeutics, we are focused on developing best-in-class medicines for people living with autoimmune and rare diseases. Leveraging our team’s expertise in antibody discovery and engineering, we have created …See details»
Leadership - Viridian Therapeutics, Inc.
Sep 11, 2023 Prior to Magenta, Shan was at Biogen where she led strategic forecasting for the multiple sclerosis global commercial organization. Previously, Shan was a management …See details»
miRagen Therapeutics, Inc. Announces Acquisition of Viridian ...
Oct 28, 2020 Management and Organization The current miRagen management team, including Lee Rauch, Chief Executive Officer, Jason A. Leverone, Chief Financial Officer, and Diana …See details»
Viridian Therapeutics - Crunchbase Company Profile
Organization. Viridian Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email info@viridiantherapeutics.com; Phone Number +1 617 272 4600; …See details»
Viridian Therapeutics, Inc. | LinkedIn
Viridian Therapeutics, Inc. | 10,950 followers on LinkedIn. Framing the future of autoimmune diseases | Viridian is a biopharmaceutical company focused on engineering and developing …See details»
Viridian Therapeutics, Inc. - Investors & Media
IR@viridiantherapeutics.com Media Contact. Media@viridiantherapeutics.com Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below …See details»
Viridian Therapeutics Inc. - AnnualReports.com
Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies.See details»
Viridian Therapeutics, Inc. Information - RocketReach
Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases.See details»
Governance Documents - Viridian Therapeutics Inc.
IR@viridiantherapeutics.com Media Contact. Media@viridiantherapeutics.com Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below …See details»
Viridian Therapeutics Company Description - Stock Analysis
2 days ago Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company’s product pipeline includes VRDN …See details»
Viridian Therapeutics - Craft
Oct 29, 2024 Viridian Therapeutics has 5 employees across 2 locations and $314 k in annual revenue in FY 2023. See insights on Viridian Therapeutics including office locations, …See details»
Viridian Therapeutics - Company Profile - Tracxn
Oct 16, 2024 Viridian Therapeutics ranks 57th among 241 active competitors. 94 of its competitors are funded while 51 have exited. Overall, Viridian Therapeutics and its …See details»
Patient Community - Viridian Therapeutics, Inc.
National Organization for Rare Disorders (NORD, USA) Rare Disease International; ... Viridian or connecting with a member of our Patient Advocacy & Engagement team, please email …See details»
Viridian Therapeutics - Overview, News & Similar companies
May 8, 2024 Viridian Therapeutics contact info: Phone number: (617) 272-4600 Website: www.viridiantherapeutics.com What does Viridian Therapeutics do? Viridian Therapeutics is …See details»
Viridian Therapeutics - VentureRadar
IL-11 is also an important effector of tumor microenvironment organization, playing a key role as a mediator between cancer and stromal cells. Applied Therapeutics USA Publicly Traded …See details»
miRagen Therapeutics Announces Company Name Change to …
Jan 19, 2021 PDF Version Jonathan Violin, Ph.D., M.B.A. appointed President, CEO and director Barrett Katz , M.D., M.B.A. joins Viridian as Chief Medical Officer Viridian is …See details»
Viridian Therapeutics - PitchBook
Viridian Therapeutics General Information Description. Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat …See details»
Viridian Therapeutics, Inc. Company Overview, Contact Details ...
Feb 19, 2024 Viridian Therapeutics Inc. launched selection of VRDN-003 as lead subcutaneous program for thyroid eye disease on Dec 18th '23. Viridian Therapeutics, Inc. (NASDAQ: …See details»
Join Our Team - Viridian Therapeutics, Inc.
At Viridian, we work with a sense of urgency for patients, creating unity with our team, the industry, and the community. We are committed to using proven science and engineering to …See details»
Viridian Therapeutics Highlights 2025 Corporate Priorities …
19 hours ago Viridian is based in Waltham, Massachusetts. For more information, please visit www.viridiantherapeutics.com. Follow Viridian on LinkedIn and X. Forward Looking …See details»